*US Central Time
Course Directors:
Nirmala Gonsalves, MD
Amanda Muir, MD, MTR
Location:
Virtual
Register Now
This series aims to equip advanced practice providers with practical, guideline-aligned approaches to the diagnosis and management of eosinophilic esophagitis (EoE). It is designed to build confidence in the use of both first-line and step-up therapies—including proton pump inhibitors, topical steroids, dietary therapy, dilation, and biologics—while emphasizing patient safety and shared decision-making. The program also focuses on standardizing longitudinal disease monitoring through symptoms, endoscopic findings (EREFS), and histology, with an emphasis on relapse prevention. Finally, it seeks to improve care coordination across gastroenterology, allergy, and nutrition services, including best practices for transitioning pediatric patients into adult care.
Part 2 addresses:
- Step-up/step-down framework and shared decision-making
- PPI dosing, trial duration, and response assessment
- Topical steroid options (viscous budesonide, fluticasone MDI): compounding tips, administration, oral candidiasis prevention
- Dietary therapy: step-up vs six-food; how to partner with dietitians; adherence strategies
- Biologics in EoE: indications, selection, baseline assessment, monitoring, safety
- Panel discussion: Therapy selection in inflammatory vs fibrostenotic phenotypes
- Take-home: Steroid slurry recipe card, diet referral pathway, patient instruction handouts
New to the series? Start with Part 1 to review the fundamentals of diagnosing eosinophilic esophagitis, including symptoms, endoscopic findings, biopsy protocols and histology.
View Part 1: Diagnosing EoE